GERMANTOWN, Maryland, and HILDEN, Germany, March 16, 2015 /PRNewswire/ — Acquisition of technology from AdnaGen enables use of innovative, non-invasive blood tests to analyze circulating tumor cells (CTCs) for personalized healthcare QIAGEN and Tokai Pharmaceuticals to co-develop and commercialize the ...
Read More »